# Repeated Doses of GnRH Agonist as Oocyte Triggering in Antagonist Protocol for Patients With Polycystic Ovary Syndrome

> **NCT04600986** · NA · COMPLETED · sponsor: **Royan Institute** · enrollment: 70 (actual)

## Conditions studied

- Polycystic Ovary Syndrome

## Interventions

- **OTHER:** Repeated dose of GnRH agonist

## Key facts

- **NCT ID:** NCT04600986
- **Lead sponsor:** Royan Institute
- **Sponsor class:** OTHER_GOV
- **Phase:** NA
- **Study type:** INTERVENTIONAL
- **Status:** COMPLETED
- **Start date:** 2020-05-30
- **Primary completion:** 2022-06-30
- **Final completion:** 2022-09-30
- **Target enrollment:** 70 (ACTUAL)
- **Last updated:** 2023-02-08


## Primary source

ClinicalTrials.gov registry: https://clinicaltrials.gov/study/NCT04600986

## Citation

> US National Library of Medicine, ClinicalTrials.gov registration NCT04600986, "Repeated Doses of GnRH Agonist as Oocyte Triggering in Antagonist Protocol for Patients With Polycystic Ovary Syndrome". Retrieved via AI Analytics 2026-05-28 from https://api.ai-analytics.org/clinical/NCT04600986. Licensed CC0.

---

*[Clinical trials dataset](/datasets/clinical-trials) · CC0 1.0*